Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Stocks in this Quantisnow insightHealth Care
Historical context for TERN
Across the 12 sessions after earlier TERN headlines, the stock closed higher 9 times and lower 3 times, with a median move of 5.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TERN | SPY |
|---|---|---|---|
| Jan 8, 2026 | Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference | -5.6% | -0.0% |
| Jan 5, 2026 | Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) | -2.3% | +0.7% |
| Dec 12, 2025 | Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares | -4.4% | -1.1% |
| Dec 10, 2025 | Terns Announces Pricing of Upsized $650 Million Public Offering | +4.8% | +0.7% |
| Dec 9, 2025 | Terns Announces Proposed Public Offering | +5.8% | -0.1% |
| Dec 8, 2025 | Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701's Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting | +37.0% | -0.3% |
Quantisnow market dataNASDAQ
TERN
Terns Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for TERN
Full TERN profile on Quantisnow Follow TERN and get a push notification the moment its next story breaks.